Publisher: American Statistical Association   (Total: 5 journals)   [Sort alphabetically]

Showing 1 - 5 of 5 Journals sorted by number of followers
J. of the American Statistical Association     Full-text available via subscription   (Followers: 72, SJR: 3.746, CiteScore: 2)
J. of Business & Economic Statistics     Full-text available via subscription   (Followers: 40, SJR: 3.664, CiteScore: 2)
J. of Statistical Software     Open Access   (Followers: 21, SJR: 13.802, CiteScore: 16)
Statistics in Biopharmaceutical Research     Full-text available via subscription   (Followers: 16, SJR: 1.187, CiteScore: 1)
Technometrics     Full-text available via subscription   (Followers: 9, SJR: 1.546, CiteScore: 2)
Similar Journals
Journal Cover
Statistics in Biopharmaceutical Research
Journal Prestige (SJR): 1.187
Citation Impact (citeScore): 1
Number of Followers: 16  
 
  Full-text available via subscription Subscription journal
ISSN (Print) 1946-6315
Published by American Statistical Association Homepage  [5 journals]
  • From Small Data to Big Data, From RCT to RWE, the Impact of Statistics:
           Selected Articles From the 2019 RISW

    • Free pre-print version: Loading...

      Authors: Judy X. Li, Renée C. Rees
      Pages: 259 - 259
      Abstract: Volume 13, Issue 3, July-September 2021, Page 259-259
      .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-08-17T02:21:15Z
      DOI: 10.1080/19466315.2021.1954419
      Issue No: Vol. 13, No. 3 (2021)
       
  • The 2019 Nonclinical Biostatistics Conference

    • Free pre-print version: Loading...

      Authors: Stan Altan, John Kolassa
      Pages: 295 - 296
      Abstract: Volume 13, Issue 3, July-September 2021, Page 295-296
      .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-08-17T02:21:17Z
      DOI: 10.1080/19466315.2021.1938444
      Issue No: Vol. 13, No. 3 (2021)
       
  • Our Most Important Discovery: The Question

    • Free pre-print version: Loading...

      Authors: Scott R. Evans
      Pages: 1 - 10
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-10-11T05:35:15Z
      DOI: 10.1080/19466315.2021.1972833
       
  • Comment on “Biostatistical Considerations When Using RWD and RWE in
           Clinical Studies for Regulatory Purposes: A Landscape Assessment”

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Yukari Uemura, Tomohiro Shinozaki, Shogo Nomura, Taro Shibata
      Pages: 1 - 3
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-10-04T02:35:29Z
      DOI: 10.1080/19466315.2021.1974537
       
  • Value Function Guided Subgroup Identification via Gradient Tree Boosting:
           A Framework to Handle Multiple Outcomes for Optimal Treatment
           Recommendation

    • Free pre-print version: Loading...

      Authors: Pingye Zhang, Peng Liu, Junshui Ma, Yue Shentu
      Pages: 1 - 9
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-10-04T02:33:55Z
      DOI: 10.1080/19466315.2021.1972832
       
  • Comment on “Biostatistical Considerations When Using RWD and RWE in
           Clinical Studies for Regulatory Purposes: A Landscape Assessment”: Is
           Real-World Evidence Real'

    • Free pre-print version: Loading...

      Authors: Chian Chen, Chin-Fu Hsiao
      Pages: 1 - 2
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-09-27T12:54:26Z
      DOI: 10.1080/19466315.2021.1969267
       
  • Closed-Form Approximation of Correlation Matrix Among Fleming Harrington
           Test Statistics in MaxCombo Test: Comments on “Robust Design and
           Analysis of Clinical Trials With Nonproportional Hazards: A Straw Man
           Guidance From a Cross-Pharma Working Group”

    • Free pre-print version: Loading...

      Authors: Madan G. Kundu
      Pages: 1 - 3
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-09-27T01:18:46Z
      DOI: 10.1080/19466315.2021.1969266
       
  • Editor’s Note

    • Free pre-print version: Loading...

      Authors: Toshimitsu Hamasaki
      Pages: 1 - 2
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-09-27T01:14:35Z
      DOI: 10.1080/19466315.2021.1964896
       
  • Multiarmed Bandit Designs for Phase I Dose-Finding Clinical Trials With
           Multiple Toxicity Types

    • Free pre-print version: Loading...

      Authors: Lan Jin, Guodong Pang, Demissie Alemayehu
      Pages: 1 - 14
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-08-31T04:31:05Z
      DOI: 10.1080/19466315.2021.1962402
       
  • Comparative Effectiveness Research using Bayesian Adaptive Designs for
           Rare Diseases: Response Adaptive Randomization Reusing Participants

    • Free pre-print version: Loading...

      Authors: Fengming Tang, Byron J. Gajewski
      Pages: 1 - 10
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-08-31T04:29:06Z
      DOI: 10.1080/19466315.2021.1961854
       
  • Statistical Inference of the Probability of Passing the USP Dissolution
           Test

    • Free pre-print version: Loading...

      Authors: Tee-Chin Chang
      Pages: 1 - 13
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-08-18T03:37:23Z
      DOI: 10.1080/19466315.2021.1953576
       
  • The Choice of a Randomization Procedure in Survival Studies with
           Nonproportional Hazards

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Marcia Viviane Rückbeil, Martin Manolov, Ralf-Dieter Hilgers
      Pages: 1 - 9
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-08-17T07:41:48Z
      DOI: 10.1080/19466315.2021.1952894
       
  • Efficiency Comparison of Analysis Methods for Recurrent Event and
           Time-to-First Event Endpoints in the Presence of Terminal
           Events—Application to Clinical Trials in Chronic Heart Failure

    • Free pre-print version: Loading...

      Authors: Arno Fritsch, Patrick Schlömer, Franco Mendolia, Tobias Mütze, Antje Jahn-Eimermacher
      Pages: 1 - 12
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-08-05T12:28:05Z
      DOI: 10.1080/19466315.2021.1945488
       
  • Quantifying Efficiency Gains of Innovative Designs of Two-Arm Vaccine
           Trials for COVID-19 Using an Epidemic Simulation Model

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Rob Johnson, Chris Jackson, Anne Presanis, Sofia S. Villar, Daniela De Angelis
      Pages: 1 - 9
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-07-30T11:55:41Z
      DOI: 10.1080/19466315.2021.1939774
       
  • Trigger Strategy in Repeated Tests on Multiple Hypotheses

    • Free pre-print version: Loading...

      Authors: Jiangtao Gou
      Pages: 1 - 8
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-07-26T01:24:02Z
      DOI: 10.1080/19466315.2021.1947361
       
  • Composite Endpoints in Cardio-Renal Clinical Outcome Trials

    • Free pre-print version: Loading...

      Authors: H. M. James Hung, John Lawrence
      Pages: 1 - 5
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-07-26T01:21:58Z
      DOI: 10.1080/19466315.2021.1945487
       
  • Generalizing Clinical Trial Results to a Target Population

    • Free pre-print version: Loading...

      Authors: Shuang Li, Daniel F. Heitjan
      Pages: 1 - 8
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-07-26T01:18:30Z
      DOI: 10.1080/19466315.2021.1942975
       
  • Using Surrogate Endpoints in Adaptive Designs with Delayed Treatment
           Effect

    • Free pre-print version: Loading...

      Authors: Qing Li, Jianchang Lin, Mengya Liu, Liwen Wu, Yingying Liu
      Pages: 1 - 10
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-07-26T01:14:15Z
      DOI: 10.1080/19466315.2021.1938203
       
  • Quick Multiple Test Procedures and p-Value Adjustments

    • Free pre-print version: Loading...

      Authors: Jiangtao Gou
      Pages: 1 - 15
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-07-12T08:40:49Z
      DOI: 10.1080/19466315.2021.1927825
       
  • Exact Properties of Some Heteroscedastic TOST Alternatives for
           Bioequivalence

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Gwowen Shieh, Show-Li Jan, Cheng-Shiun Leu
      Pages: 1 - 10
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-07-12T08:29:19Z
      DOI: 10.1080/19466315.2021.1927826
       
  • The Strong Null Hypothesis and the MaxCombo Test: Comment on “Robust
           Design and Analysis of Clinical Trials with Nonproportional Hazards: A
           Straw Man Guidance form a Cross-Pharma Working Group.”

    • Free pre-print version: Loading...

      Authors: Dominic Magirr, Carl-Fredrik Burman
      Pages: 1 - 2
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-07-06T02:53:55Z
      DOI: 10.1080/19466315.2021.1917451
       
  • Comment on “Robust Design and Analysis of Clinical Trials With
           Nonproportional Hazards: A Straw Man Guidance From a Cross-Pharma Working
           Group”: The Test Statistic Should Estimate Some Reasonable Measure of
           Treatment Benefit

    • Free pre-print version: Loading...

      Authors: Steven Snapinn, Qi Jiang, Chunlei Ke
      Pages: 1 - 3
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-07-06T02:51:58Z
      DOI: 10.1080/19466315.2021.1924258
       
  • Use of Nonconcurrent Common Control in Master Protocols in Oncology
           Trials: Report of an American Statistical Association Biopharmaceutical
           Section Open Forum Discussion

    • Free pre-print version: Loading...

      Authors: Rajeshwari Sridhara, Olga Marchenko, Qi Jiang, Richard Pazdur, Martin Posch, Scott Berry, Marc Theoret, Yuan Li Shen, Thomas Gwise, Lorenzo Hess, Andrew Raven, Khadija Rantell, Kit Roes, Richard Simon, Mary Redman, Yuan Ji, Cindy Lu
      Pages: 1 - 5
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-07-06T01:25:59Z
      DOI: 10.1080/19466315.2021.1938204
       
  • Applying Quantitative Approaches in the Use of RWE in Clinical Development
           and Life-Cycle Management

    • Free pre-print version: Loading...

      Authors: Weili He, Yixin Fang, Hongwei Wang, Ivan Chan
      Pages: 1 - 12
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-07-06T01:21:58Z
      DOI: 10.1080/19466315.2021.1927827
       
  • Statistical Models for Composite Endpoints of Death and Nonfatal Events: A
           Review

    • Free pre-print version: Loading...

      Authors: Lu Mao, KyungMann Kim
      Pages: 1 - 10
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-07-06T01:16:08Z
      DOI: 10.1080/19466315.2021.1927824
       
  • Simulation-Based Pharmacokinetics Sampling Design for Evaluating
           Correlates of Prevention Efficacy of Passive HIV Monoclonal Antibody
           Prophylaxis

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Lily Zhang, Peter B. Gilbert, Edmund Capparelli, Yunda Huang
      Pages: 1 - 15
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-06-28T03:15:28Z
      DOI: 10.1080/19466315.2021.1919196
       
  • A Test for Treatment Effects Based on the Exact Distribution of an
           Ordinary Least-Square Estimator in Sequential Parallel Comparison Design

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Jun Tsuchida, Yu Miyauchi, Shuji Ando, Takashi Sozu
      Pages: 1 - 10
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-06-18T01:20:38Z
      DOI: 10.1080/19466315.2021.1924257
       
  • Bayesian Approaches for Handling Hypothetical Estimands in Longitudinal
           Clinical Trials With Gaussian Outcomes

    • Free pre-print version: Loading...

      Authors: G. Frank Liu, Jiajun Liu, Fang Chen, Roee Gutman, Kaifeng Lu
      Pages: 1 - 10
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-06-18T01:16:19Z
      DOI: 10.1080/19466315.2021.1924256
       
  • Statistical Observations on Vaccine Clinical Development for Pandemic
           Diseases

    • Free pre-print version: Loading...

      Authors: Scott Patterson, Bo Fu, Ya Meng, Fabrice Bailleux, Josh Chen
      Pages: 1 - 5
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-06-01T01:48:15Z
      DOI: 10.1080/19466315.2021.1919197
       
  • Planning for the Next Pandemic: Ethics and Innovation Today for Improved
           Clinical Trials Tomorrow

    • Free pre-print version: Loading...

      Authors: Gianna McMillan, Cristiana Mayer, Rui Tang, Yi Liu, Lisa LaVange, Zoran Antonijevic, Robert A. Beckman
      Pages: 1 - 6
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-06-01T01:44:08Z
      DOI: 10.1080/19466315.2021.1918236
       
  • On the Implementation of Robust Meta-Analytical-Predictive Prior

    • Free pre-print version: Loading...

      Authors: Hongtao Zhang, Alan Y Chiang, Mike Branson
      Pages: 1 - 9
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-06-01T01:34:00Z
      DOI: 10.1080/19466315.2021.1917450
       
  • Teasing Out the Overall Survival Benefit With Adjustment for Treatment
           Switching to Multiple Treatments

    • Free pre-print version: Loading...

      Authors: Yuqing Xu, Meijing Wu, Weili He, Qiming Liao, Yabing Mai
      Pages: 1 - 10
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-05-18T06:42:41Z
      DOI: 10.1080/19466315.2021.1914716
       
  • A Generalized Framework of Optimal Two-Stage Designs for Exploratory
           Basket Trials

    • Free pre-print version: Loading...

      Authors: Xiaoqiang Wu, Cai (Iris) Wu, Fang Liu, Heng Zhou, Cong Chen
      Pages: 1 - 9
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-05-18T06:36:51Z
      DOI: 10.1080/19466315.2021.1906741
       
  • A Seamless Adaptive 2-in-1 Design Expanding a Phase 2 Trial for Treatment
           or Dose Selection Into a Phase 3 Trial

    • Free pre-print version: Loading...

      Authors: Man Jin, Pingye Zhang
      Pages: 1 - 8
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-05-04T07:19:10Z
      DOI: 10.1080/19466315.2021.1914717
       
  • Type I Error Considerations in Master Protocols With Common Control in
           Oncology Trials: Report of an American Statistical Association
           Biopharmaceutical Section Open Forum Discussion

    • Free pre-print version: Loading...

      Authors: Rajeshwari Sridhara, Olga Marchenko, Qi Jiang, Richard Pazdur, Martin Posch, Mary Redman, Yevgen Tymofyeyev, Xiaoyun (Nicole) Li, Marc Theoret, Yuan Li Shen, Thomas Gwise, Lorenzo Hess, Michael Coory, Andrew Raven, Naoto Kotani, Kit Roes, Filip Josephson, Scott Berry, Richard Simon, Bruce Binkowitz
      Pages: 1 - 4
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-04-28T01:32:32Z
      DOI: 10.1080/19466315.2021.1906743
       
  • A Phase 3 Trial Analysis Proposal for Mitigating the Impact of the
           COVID-19 Pandemic

    • Free pre-print version: Loading...

      Authors: Eva Hua, Reinhold Janocha, Thomas Severin, Jiawei Wei, Marc Vandemeulebroecke
      Pages: 1 - 7
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-04-28T01:28:41Z
      DOI: 10.1080/19466315.2021.1905056
       
  • Estimands for Recurrent Event Endpoints in the Presence of a Terminal
           Event

    • Free pre-print version: Loading...

      Authors: Heinz Schmidli, James H. Roger, Mouna Akacha
      Pages: 1 - 11
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-04-19T01:09:45Z
      DOI: 10.1080/19466315.2021.1895883
       
  • Statistical Inference on the Estimators of the Adherer Average Causal
           Effect

    • Free pre-print version: Loading...

      Authors: Ying Zhang, Haoda Fu, Stephen J. Ruberg, Yongming Qu
      Pages: 1 - 4
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-03-22T02:17:44Z
      DOI: 10.1080/19466315.2021.1891965
       
  • The Current Landscape in Biostatistics of Real-World Data and Evidence:
           Causal Inference Frameworks for Study Design and Analysis

    • Free pre-print version: Loading...

      Authors: Martin Ho, Mark van der Laan, Hana Lee, Jie Chen, Kwan Lee, Yixin Fang, Weili He, Telba Irony, Qi Jiang, Xiwu Lin, Zhaoling Meng, Pallavi Mishra-Kalyani, Frank Rockhold, Yang Song, Hongwei Wang, Roseann White
      Pages: 1 - 14
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-03-15T01:39:02Z
      DOI: 10.1080/19466315.2021.1883475
       
  • The Current Landscape in Biostatistics of Real-World Data and Evidence:
           Clinical Study Design and Analysis

    • Free pre-print version: Loading...

      Authors: Jie Chen, Martin Ho, Kwan Lee, Yang Song, Yixin Fang, Benjamin A Goldstein, Weili He, Telba Irony, Qi Jiang, Mark van der Laan, Hana Lee, Xiwu Lin, Zhaoling Meng, Pallavi Mishra-Kalyani, Frank Rockhold, Hongwei Wang, Roseann White
      Pages: 1 - 14
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-03-15T01:34:48Z
      DOI: 10.1080/19466315.2021.1883474
       
  • Deep Learning Based Multimodal Progression Modeling for Alzheimer’s
           Disease

    • Free pre-print version: Loading...

      Authors: Liuqing Yang, Xifeng Wang, Qi Guo, Scott Gladstein, Dustin Wooten, Tengfei Li, Weining Z Robieson, Yan Sun, Xin Huang
      Pages: 1 - 7
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-03-10T02:52:31Z
      DOI: 10.1080/19466315.2021.1884129
       
  • Biostatistical Considerations When Using RWD and RWE in Clinical Studies
           for Regulatory Purposes: A Landscape Assessment

    • Free pre-print version: Loading...

      Authors: Mark Levenson, Weili He, Jie Chen, Yixin Fang, Douglas Faries, Benjamin A. Goldstein, Martin Ho, Kwan Lee, Pallavi Mishra-Kalyani, Frank Rockhold, Hongwei Wang, Richard C. Zink
      Pages: 1 - 11
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-03-10T02:39:15Z
      DOI: 10.1080/19466315.2021.1883473
       
  • Discrete Time Multistate Model With Regime Switching for Modeling COVID-19
           Disease Progression and Clinical Outcomes

    • Free pre-print version: Loading...

      Authors: Sujatro Chakladar, Ran Liao, Will Landau, Margaret Gamalo, Yanping Wang
      Pages: 1 - 15
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-03-10T02:21:30Z
      DOI: 10.1080/19466315.2021.1880966
       
  • Dynamic Monitoring of Ongoing Clinical Trials
         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Tai Xie, Peng Zhang, Weichung Joe Shih, Yue Tu, K. K. Gordon Lan
      Pages: 1 - 12
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-03-08T07:37:08Z
      DOI: 10.1080/19466315.2021.1880965
       
  • Evaluating Misclassification Effects on Single Sequential Treatment in
           Sequential Multiple Assignment Randomized Trial (SMART) Designs

    • Free pre-print version: Loading...

      Authors: Jun He, Donna K. McClish, Roy T. Sabo
      Pages: 1 - 8
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-03-04T04:59:01Z
      DOI: 10.1080/19466315.2021.1883472
       
  • Robust Design and Analysis of Clinical Trials With Nonproportional
           Hazards: A Straw Man Guidance From a Cross-Pharma Working Group

    • Free pre-print version: Loading...

      Authors: Satrajit Roychoudhury, Keaven M Anderson, Jiabu Ye, Pralay Mukhopadhyay
      Pages: 1 - 15
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-03-04T04:58:40Z
      DOI: 10.1080/19466315.2021.1874507
       
  • Comparison of Sample Size Requirements of Randomized and Historically
           Controlled Trials Based on Calibrated Error Rates

    • Free pre-print version: Loading...

      Authors: Srinand Nandakumar, Steven M. Snapinn
      Pages: 1 - 5
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-02-26T08:17:45Z
      DOI: 10.1080/19466315.2020.1867633
       
  • Least Conservative Critical Boundaries of Multiple Hypothesis Testing in a
           Range of Correlation Values

    • Free pre-print version: Loading...

      Authors: Jiangtao Gou
      Pages: 1 - 9
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-02-10T02:14:32Z
      DOI: 10.1080/19466315.2021.1873842
       
  • Statistical Opportunities to Accelerate Development for COVID-19
           Therapeutics

    • Free pre-print version: Loading...

      Authors: Fanni Natanegara, Névine Zariffa, Joan Buenconsejo, Ran Liao , Freda Cooner, Divya Lakshminarayanan, Samiran Ghosh, Jerald S. Schindler, Margaret Gamalo
      Pages: 1 - 17
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-02-09T02:15:16Z
      DOI: 10.1080/19466315.2020.1865195
       
  • A Bayesian Decision-Theoretic Design for Simultaneous Biomarker-Based
           Subgroup Selection and Efficacy Evaluation

    • Free pre-print version: Loading...

      Authors: Zheyu Wang, Fujun Wang, Chenguang Wang, Jianliang Zhang, Hao Wang, Li Shi, Zhuojun Tang, Gary L. Rosner
      Pages: 1 - 12
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-02-09T02:14:57Z
      DOI: 10.1080/19466315.2021.1873843
       
  • Post-Test Diagnostic Accuracy Measures of a Continuous Test With a Disease
           of Ordinal Multistages

    • Free pre-print version: Loading...

      Authors: Hani Samawi, Jingjing Yin, Haresh Rochani, Chen Mo, Jing Kersey
      Pages: 1 - 7
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-02-09T02:12:58Z
      DOI: 10.1080/19466315.2021.1873841
       
  • On Identification of the Principal Stratum Effect in Patients Who Would
           Comply If Treated

    • Free pre-print version: Loading...

      Authors: Oliver Dukes, Kelly Van Lancker, Björn Bornkamp, Dominik Heinzmann, Kaspar Rufibach, Marcel Wolbers
      Pages: 1 - 3
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-02-09T02:08:47Z
      DOI: 10.1080/19466315.2021.1872697
       
  • An Empirical Comparison of Segmented and Stochastic Linear Mixed Effects
           Models to Estimate Rapid Disease Progression in Longitudinal Biomarker
           Studies

    • Free pre-print version: Loading...

      Authors: Weiji Su, Emrah Gecili, Xia Wang, Rhonda D. Szczesniak
      Pages: 1 - 10
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-02-04T07:11:44Z
      DOI: 10.1080/19466315.2020.1870546
       
  • A Comparative Study on the SWOG Two-Stage Design Extension to Stop Early
           for Efficacy in Single Arm Phase II Trials

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Monica Chaudhari, John Crowley, Antje Hoering
      Pages: 1 - 10
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-02-01T02:38:22Z
      DOI: 10.1080/19466315.2020.1865194
       
  • Quantitative Decision Under Unequal Covariances and Post-Treatment
           Variances: A Kidney Disease Application

    • Free pre-print version: Loading...

      Authors: Macaulay Okwuokenye
      Pages: 1 - 12
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-01-28T01:59:41Z
      DOI: 10.1080/19466315.2020.1864464
       
  • Model-Based Clustering and Prediction With Mixed Measurements Involving
           Surrogate Classifiers

    • Free pre-print version: Loading...

      Authors: Hua Shen, Alexander R. de Leon
      Pages: 1 - 12
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-01-26T02:48:39Z
      DOI: 10.1080/19466315.2020.1863257
       
  • Hierarchical Generalized Linear Models for Multiregional Clinical Trials

    • Free pre-print version: Loading...

      Authors: Junhui Park, Seung-Ho Kang
      Pages: 1 - 10
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-01-26T02:44:17Z
      DOI: 10.1080/19466315.2020.1862702
       
  • Mitigating Study Power Loss Caused by Clinical Trial Disruptions Due to
           the COVID-19 Pandemic: Leveraging External Data via Propensity
           Score-Integrated Approaches

    • Free pre-print version: Loading...

      Authors: Heng Li, Wei-Chen Chen, Nelson Lu, Changhong Song, Chenguang Wang, Ram Tiwari, Yunling Xu, Lilly Q. Yue
      Pages: 1 - 5
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-01-26T02:42:24Z
      DOI: 10.1080/19466315.2020.1860813
       
  • Repeated Measures Analysis of the Sequential Parallel Comparison Design
           With Normal Responses

    • Free pre-print version: Loading...

      Authors: Kaifeng Lu, Yangchun Du
      Pages: 1 - 11
      Abstract: .

      Citation: Statistics in Biopharmaceutical Research
      PubDate: 2021-01-04T01:28:51Z
      DOI: 10.1080/19466315.2020.1860120
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 3.236.218.88
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-